生命科学资讯

FDA slaps highest-risk recall notice on J&J Medtech Cerepak detachable coils

QuantX raises $85M Series B from Lilly, Sanofi Ventures

Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals

Despite FDA’s crackdown, pharma is still spending millions on ads

Takeda inks $1.7B AI drug discovery deal with Iambic Therapeutics

Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena

Lilly bets again on China drugs; Roche showcases MS data

Thermo Fisher Scientific Inc files for four-part senior notes offering size not disclosed - marketscreener.com

Lilly joins in vivo CAR-T sprint with $2.4B Orna acquisition

Galux raises $29M Series B; CSL teams up with Memo

My path to Illumina - Illumina

Innovent-Lilly $8.5B deal signals new China inflection point

Biggest gainers and losers for Feb. 2-6, 2026

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation - Becton Dickinson

#ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%

CUL5 E3 ubiquitin ligase regulates the evasion of bladder cancer cells to CD8+ T cell-mediated killing by inhibiting autophagy

Takeda, Iambic sign multiyear R&D deal for AI drug discovery

New diagnostics define drug targets for Alzheimer’s, Parkinson’s and beyond

Venenum Biodesign discloses new MOGAT2 inhibitors

Korean researchers report new HER1/HER2 mutant inhibitors